We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
First French Pharma to Fully Automate Cell Culture Chooses CompacT SelecT™ from The Automation Partnership
News

First French Pharma to Fully Automate Cell Culture Chooses CompacT SelecT™ from The Automation Partnership

First French Pharma to Fully Automate Cell Culture Chooses CompacT SelecT™ from The Automation Partnership
News

First French Pharma to Fully Automate Cell Culture Chooses CompacT SelecT™ from The Automation Partnership

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "First French Pharma to Fully Automate Cell Culture Chooses CompacT SelecT™ from The Automation Partnership"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

The Automation Partnership (TAP) has announced that Laboratoires Fournier S.A., a French subsidiary of the international chemical and pharmaceutical group Solvay S.A., has chosen a CompacT SelecT™, automated cell culture system to increase the productivity of their cell line maintenance and cell-based screening activities.

The CompacT SelecT is a smaller and more affordable version of TAP’s internationally successful high throughput SelecT™ system.

The system at Laboratoires Fournier S.A. will be the first fully automated cell culture system installed in a pharmaceutical company operating in France.

CompacT SelecT manages the entire cell culture process from growing and maintaining cells in T-flasks to delivering cells in assay-ready plates.

It uses a 6-axis anthropomorphic robotic arm to process up to 130 T-175 flasks and 210 microplates and bar code tracking to ensure cell line security and traceability.

Ultimately, it offers a level of flexibility and processing power previously unavailable to medium throughput laboratories and has the potential to increase cell culture productivity by more than 20 per cent.

Tim Ward, Cell Culture Business Unit Director at TAP commented: “We are delighted that the CompacT SelecT is going to be the first fully automated cell culture system installed in a French pharma.

This is the sixth CompacT SelecT system we have sold world-wide and shows that for forward thinking, growing pharmas and biotechs wanting to significantly increase their cell culture productivity, having a CompacT SelecT is rapidly becoming an essential investment.” 

Advertisement